CN Patent

CN121194965A — 盐酸奥扎莫德的无定形形式和晶型

Assigned to Quimikaxin Tetika Co ltd · Expires 2025-12-23 · 0y expired

What this patent protects

描述了具有下式(I)的盐酸奥扎莫德的新固体形式。此外，还描述了用于所述固体形式的制备方法，以及包含它们的药物组合物。

USPTO Abstract

描述了具有下式(I)的盐酸奥扎莫德的新固体形式。此外，还描述了用于所述固体形式的制备方法，以及包含它们的药物组合物。

Drugs covered by this patent

ozanimod-hydrochloride (OZANIMOD HYDROCHLORIDE)

Patent Metadata

Patent number: CN121194965A
Jurisdiction: CN
Classification: —
Expires: 2025-12-23
Drug substance claim: No
Drug product claim: No
Assignee: Quimikaxin Tetika Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.